Provid Pharmaceuticals
Manufacturing · New Jersey, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
7 Deerpark Dr Ste M11, Monmouth Junction...Phone Number
(732) 565-1101Website
www.provid.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Provid Pharmaceuticals
Provid Pharmaceuticals is focused on pioneering MHC inhibition to develop innovative treatments for multiple sclerosis (MS) and other autoimmune diseases. Their lead drug candidate, PV-3212, is a potent inhibitor targeting the HLA-DRB1*15:01 (DR15) molecule, which is genetically associated with MS. The company offers drug discovery services, including expert medicinal chemistry and therapeutic expertise, aimed at addressing various autoimmune disease targets. Their intended clients include partners and investors interested in advancing drug development in the field of autoimmune diseases.Explore more
Provid Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Provid Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Provid Pharmaceuticals launches new products
Congratulate Masked Content for being promoted to Masked Content at Provid Pharmaceuticals
Provid Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if Provid Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Click to see if Provid Pharmaceuticals had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Provid Pharmaceuticals has new funding data
Check out if Provid Pharmaceuticals is spiking on competitors!
Earning: See what the market has to say on Provid Pharmaceuticals recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Provid Pharmaceuticals
Find 2 more new buyers
Compare Similar Companies to Provid Pharmaceuticals
Compare insights from companies similar to Provid Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Provid Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Provid Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Provid Pharmaceuticals.
Provid Pharmaceuticals financials insights
Gather financial insights about Provid Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$37K
Provid Pharmaceuticals Tech Stack
A closer look at the technologies used by Provid Pharmaceuticals
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Provid Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Provid Pharmaceuticals is focused on pioneering MHC inhibition to develop innovative treatments for multiple sclerosis (MS) and other autoimmune diseases. Their lead drug candidate, PV-3212, is a potent inhibitor targeting the HLA-DRB1*15:01 (DR15) molecule, which is genetically associated with MS. The company offers drug discovery services, includ... Read More
